WSJ Live
$1,000-a-Day Hepatitis C Drug Is a Blockbuster
Runaway demand for a life-saving hepatitis C treatment that costs $1,000 a day could send insurers' earnings per share down by double-digit percentages this year. Jonathan Rockoff reports on Lunch Break.
No comments:
Post a Comment